The Finish Line's stock has surged 79% a year, on average, since 2008. It has advanced 39% in 12 months, but has fallen nearly 8% in three. Of stock analysts covering the equity, 13, or 93%, advise purchasing it and one recommends holding. None advocate selling the shares. The stock has a median target of $22.45, implying a 12-month rise of 32%. Sidoti & Co. values the equity at $26, consistent with a gain of 52%. Citigroup isn't as optimistic, ranking the stock "hold" with a $19 target. The Finish Line sells at sizable discounts to peer stocks.
It trades at a trailing earnings multiple of 15, a forward earnings multiple of 12, a book value multiple of 2, a sales multiple of 0.8 and a cash flow multiple of 7.2, 22%, 24%, 38%, 22% and 41% discounts to specialty retail industry averages. Its PEG ratio of 0.4 indicates a 60% discount to estimated fair value. The Finish Line's fiscal third-quarter adjusted earnings multiplied to eight cents, exceeding analysts' consensus estimate by 51%. Sales, up 8.7%, outperformed consensus by 4.4%. The Finish Line will report quarterly results Mar. 24.